PDR MEMBER LOGIN:
  • PDR Search

    Required field
  • IMPORTANT DRUG WARNING

    Product: Xeljanz® (tofacitinib)
    Posted On: December 16, 2021
    MANUFACTURER: Pfizer
    AUDIENCE: Prescribers: AMA Rheumatology, Gastroenterology, Dermatology, Internal Medicine, Family Medicine, Pediatricians, and Pediatric Rheumatology. Nurse Practitioners and Physician Assistants. Pharmacists and all licensed Pharmacies.

    If unable to view, click here to download this file to your computer.